Brief: Harvard Apparatus Regenerative Technology Q4 loss $0.17/share
March 17 (Reuters) - Harvard Apparatus Regenerative
Technology Inc HART.O :
* Q4 loss per share $0.17
Source text for Eikon: ID:nPn7yJ2Jha
Further company coverage: HART.O
((Bengaluru Newsroom; +1 646 223 8780;))
Recent news on Harvard Apparatus Regenerative Technology
See all newsBrief: Harvard Apparatus Regenerative Technology Announces Strategic Collaboration With Children’S Hospital Capital Institute Of Pediatrics In Beijing, China To Advance Treatment For Esophageal Atresia
Brief: Biostage Activated Mayo Clinic As The First Site For Clinical Trial In Severe Esophageal Disease
Brief: Biostage Amends CEO Employment Agreement
Brief: Biostage Inc Files For Firm Commitment Public Offering Of 1.03 Million Units - SEC Filing
Brief: Biostage Announces Appointment Of New Chief Financial Officer